AAPL 207.19 -0.19 (-0.09%)MSFT 129.17 +4.11 (+3.29%)FB 193.85 +2.77 (+1.45%)ZNGA 5.58 0 (+0.09%)NVDA 191.18 -0.12 (-0.06%)WBA 53.48 -0.04 (-0.07%)GOOG 1256.05 -0.4 (-0.03%)PIH 5.25 -0.05 (-0.94%)
AAPL 207.19 -0.19 (-0.09%)MSFT 129.17 +4.11 (+3.29%)FB 193.85 +2.77 (+1.45%)ZNGA 5.58 0 (+0.09%)NVDA 191.18 -0.12 (-0.06%)WBA 53.48 -0.04 (-0.07%)GOOG 1256.05 -0.4 (-0.03%)PIH 5.25 -0.05 (-0.94%)

Company Profile ADAP Quote Adaptimmune

Adaptimmune Therapeutics plc Quote

Adaptimmune The (ADAP)

4.24 -0.01 Healthcare

CEO

James J. Noble

Sector

Healthcare

Industry

Biotechnology

Exchange

Nasdaq Global Select

Description

Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform.